1. Home
  2. APPS vs COLL Comparison

APPS vs COLL Comparison

Compare APPS & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digital Turbine Inc.

APPS

Digital Turbine Inc.

HOLD

Current Price

$10.50

Market Cap

1.2B

Sector

Miscellaneous

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$22.93

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APPS
COLL
Founded
N/A
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
APPS
COLL
Price
$10.50
$22.93
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
$17.00
★ $49.00
AVG Volume (30 Days)
★ 2.5M
674.2K
Earning Date
11-02-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 62.92
N/A
EPS
N/A
★ N/A
Revenue
$103,569,000.00
★ $780,567,000.00
Revenue This Year
$17.68
$6.73
Revenue Next Year
$11.78
$1.37
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 38.55
23.62
52 Week Low
$2.74
$21.43
52 Week High
$15.34
$50.79

Technical Indicators

Market Signals
Indicator
APPS
COLL
Relative Strength Index (RSI) 49.11 48.24
Support Level $10.07 $21.51
Resistance Level $10.80 $23.69
Average True Range (ATR) 0.68 0.65
MACD -0.07 0.31
Stochastic Oscillator 54.71 54.60

Price Performance

Historical Comparison
APPS
COLL

About APPS Digital Turbine Inc.

Digital Turbine Inc is an independent mobile growth platform that levels up the landscape for advertisers, publishers, carriers, and device original equipment manufacturers. The Company offers end-to-end products and solutions leveraging proprietary technology to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. In addition, its products and solutions provide monetization opportunities for OEMs, carriers, and application (app or apps) publishers and developers.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: